In the context of CRC, SCFA supplementation led to a homeostatic dysregulation via hyperactivation of Wnt/β-catenin as well as TGF-β signaling pathways and activation of MYC, FOS and JUN oncogenes. The gene discussed is MYC; the disease is colorectal carcinoma.